Avalon GloboCare Announces Filing of Provisional Patent Applications for AVA-101, a Novel Transposon-Based, Multi-Targeted CAR-T Therapy The Bakersfield Californian
AVA-101 designed to enhance efficacy and overcome safety challenges of current CAR-T immune-oncology therapeutics.